Zentiva Pharmaceuticals

Zentiva is a leading European pharmaceutical company with a rich heritage that traces its roots back to the Black Eagle Pharmacy in Prague, founded in 1488. The modern incarnation of the brand emerged as a major player in the generics market throughout the 20th century, particularly within Central and Eastern Europe. Today, it focuses on providing high-quality, affordable medicines including international non-proprietary names (INN) and branded generics across various therapeutic areas.

The company operates several major manufacturing sites to support its international distribution, with primary production facilities located in Prague (Czech Republic) and Bucharest (Romania). These sites are complemented by a global supply chain that allows Zentiva to reach millions of patients across Europe and beyond.

Historically, Zentiva was under the ownership of Sanofi for many years. However, in 2018, it was acquired by Advent International, a global private equity firm. Under this ownership, Zentiva has expanded through strategic acquisitions, such as the purchase of Alvogen's CEE business, solidifying its position as an independent pan-European leader in the generic medicines sector.